Delivery and performance of surfactant replacement therapies to treat pulmonary disorders

N El-Gendy, A Kaviratna, C Berkland… - Therapeutic delivery, 2013‏ - Taylor & Francis
Lung surfactant is crucial for optimal pulmonary function throughout life. An absence or
deficiency of surfactant can affect the surfactant pool leading to respiratory distress. Even if …

Nanovesicle aerosols as surfactant therapy in lung injury

AS Kaviratna, R Banerjee - Nanomedicine: Nanotechnology, Biology and …, 2012‏ - Elsevier
Acute lung injury causes inactivation of pulmonary surfactant due to leakage of albumin and
other markers. Current surfactants are ineffective in this condition and are instilled …

Surface patterning of single-walled carbon nanotubes enhances their perturbation on a pulmonary surfactant monolayer: frustrated translocation and bilayer …

T Yue, Y Xu, S Li, Z Luo, X Zhang, F Huang - RSC Advances, 2017‏ - pubs.rsc.org
The pulmonary surfactant monolayer (PSM) is a complex material lining the air–water
interface of lung alveoli to avoid its collapse by reducing surface tension. Once external …

Mitigation of hydrochloric acid (HCl)-induced lung injury in mice by aerosol therapy of surface-active nanovesicles containing antioxidant and anti-inflammatory drugs

AR Shah, R Banerjee - ACS Applied Bio Materials, 2019‏ - ACS Publications
Acute lung injury leading to alveolar inflammation and surfactant dysfunction remains a
medical challenge. Surface-active lipid nanovesicles of 200–250 nm size with antioxidant D …